Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Glucosamine + Chondroitin | Melatonin | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 1500mg glucosamine sulfate + 1200mg chondroitin sulfate daily | 0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision) |
| Timing | With meals, split into 2-3 doses. Full clinical benefit requires 8-12 weeks of consistent use. | 30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking. |
| Cycle Duration | ongoing (minimum 3 months to assess response) | Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision |
| Evidence Level | moderate_human | strong_human |
Glucosamine serves as a substrate for glycosaminoglycan (GAG) and proteoglycan biosynthesis in articular cartilage. It stimulates chondrocyte production of type II collagen and proteoglycans while inhibiting MMP-3 and aggrecanase enzymes that degrade cartilage matrix. Chondroitin sulfate provides osmotic swelling pressure in cartilage (water retention), inhibits complement-mediated inflammation, and downregulates NF-kB and IL-1beta in synoviocytes. Together they exert synergistic chondroprotective and mild anti-inflammatory effects.
1500mg glucosamine sulfate + 1200mg chondroitin sulfate daily
With meals, split into 2-3 doses. Full clinical benefit requires 8-12 weeks of consistent use.
ongoing (minimum 3 months to assess response)
Melatonin (N-acetyl-5-methoxytryptamine) is synthesized from serotonin in the pineal gland, regulated by the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract. It binds MT1 and MT2 G-protein coupled receptors: MT1 activation suppresses neuronal firing in the SCN (sleep onset), while MT2 modulates circadian phase shifting. Beyond sleep, melatonin is a potent antioxidant that scavenges hydroxyl radicals, peroxynitrite, and singlet oxygen, and upregulates antioxidant enzymes (GPx, SOD, catalase) via Nrf2. It has anti-inflammatory properties (NF-kB suppression), immunomodulatory effects, oncostatic activity (anti-proliferative in several cancer types), and mitochondrial protective functions.
0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision)
30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking.
Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision
Fast buy links (we may earn a small commission at no extra cost).
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →